Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Curr Opin Cardiol. 2021 Jul 1;36(4):429–435. doi: 10.1097/HCO.0000000000000864

Figure 2:

Figure 2:

Proposed algorithm for screening adults with hypertension for renin-independent aldosterone production, as adapted on the basis of new information in References 22** and 25, with permission. Those with a positive screen may be considered for early mineralocorticoid receptor antagonist (spironolactone or eplerenone) treatment. Those with an overtly positive screen should be referred to a specialist for a formal workup of primary aldosteronism. PRA, plasma renin activity.